Phase II study of sunitinib malate in patients with recurrent high-grade glioma.
Neyns B, Sadones J, Chaskis C, Dujardin M, Everaert H, Lv S, Duerinck J, Tynninen O, Nupponen N, Michotte A, De Greve J.
Neyns B, et al. Among authors: dujardin m.
J Neurooncol. 2011 Jul;103(3):491-501. doi: 10.1007/s11060-010-0402-7. Epub 2010 Sep 25.
J Neurooncol. 2011.
PMID: 20872043
Clinical Trial.